H79TI087770
Project Grant
Overview
Grant Description
Kentucky Overdose Response Effort - The Kentucky Overdose Response Effort (KORE) supports the implementation of a comprehensive response to Kentucky's opioid and stimulant crisis by expanding access to evidence-based prevention, treatment, and recovery support services.
Central to KORE’s approach is a behavioral health system infrastructure with the capacity to deliver high-quality, evidence-based interventions in a data-driven, equitable, and trauma-informed manner.
Addressing the evolving and expanding epidemic is a top priority across all levels of government and community partners in Kentucky.
Opioid and stimulant overdose remains one of the most critical public health and safety issues facing the Commonwealth of Kentucky.
Although overdose deaths decreased by 9.8% from 2022 to 2023—a reduction that was three times the national average—1,984 Kentuckians died from a drug overdose, and most of these fatalities involved fentanyl (79%) and methamphetamine (55%).
Informed by KORE’s strategic action plan, populations of focus include individuals with opioid use disorder (OUD) or stimulant use disorder (STIMUD) who are 1) overdose survivors; 2) criminal-legal system-involved; 3) pregnant and postpartum; 4) Black, Indigenous, and People of Color (BIPOC); and 5) transition-age youth.
The goals of Kentucky’s State Opioid Response Grant are to 1) prevent the development of OUD and STIMUD by implementing evidence-based interventions that address behaviors that may lead to a use disorder or overdose; 2) reduce overdose fatalities and other negative impacts of opioid and stimulant use through expansion of harm reduction strategies and principles; 3) reduce OUD/STIMUD, overdose, and related health consequences by increasing equitable availability and accessibility of evidence-based treatments that include the use of FDA-approved medications for opioid use disorder (MOUD); and 4) facilitate and sustain long-term recovery from OUD/STIMUD by increasing access to support services that build recovery capital.
Kentucky proposes to serve 104,000 individuals in year 1, 154,000 in year 2, and 154,000 in year 3.
Grant activities will be prioritized in catchment areas with high rates of opioid or stimulant overdose, which include Appalachian Eastern KY, Northern KY, Central KY, and Greater Jefferson County.
Through the State Opioid Response Grant, Kentucky will be better equipped to support the behavioral health needs of the Commonwealth and implement evidence-based interventions to end the opioid and stimulant epidemic.
Central to KORE’s approach is a behavioral health system infrastructure with the capacity to deliver high-quality, evidence-based interventions in a data-driven, equitable, and trauma-informed manner.
Addressing the evolving and expanding epidemic is a top priority across all levels of government and community partners in Kentucky.
Opioid and stimulant overdose remains one of the most critical public health and safety issues facing the Commonwealth of Kentucky.
Although overdose deaths decreased by 9.8% from 2022 to 2023—a reduction that was three times the national average—1,984 Kentuckians died from a drug overdose, and most of these fatalities involved fentanyl (79%) and methamphetamine (55%).
Informed by KORE’s strategic action plan, populations of focus include individuals with opioid use disorder (OUD) or stimulant use disorder (STIMUD) who are 1) overdose survivors; 2) criminal-legal system-involved; 3) pregnant and postpartum; 4) Black, Indigenous, and People of Color (BIPOC); and 5) transition-age youth.
The goals of Kentucky’s State Opioid Response Grant are to 1) prevent the development of OUD and STIMUD by implementing evidence-based interventions that address behaviors that may lead to a use disorder or overdose; 2) reduce overdose fatalities and other negative impacts of opioid and stimulant use through expansion of harm reduction strategies and principles; 3) reduce OUD/STIMUD, overdose, and related health consequences by increasing equitable availability and accessibility of evidence-based treatments that include the use of FDA-approved medications for opioid use disorder (MOUD); and 4) facilitate and sustain long-term recovery from OUD/STIMUD by increasing access to support services that build recovery capital.
Kentucky proposes to serve 104,000 individuals in year 1, 154,000 in year 2, and 154,000 in year 3.
Grant activities will be prioritized in catchment areas with high rates of opioid or stimulant overdose, which include Appalachian Eastern KY, Northern KY, Central KY, and Greater Jefferson County.
Through the State Opioid Response Grant, Kentucky will be better equipped to support the behavioral health needs of the Commonwealth and implement evidence-based interventions to end the opioid and stimulant epidemic.
Funding Goals
ADDRESSING THE OPIOID ABUSE CRISIS WITHIN SUCH STATES, USED FOR CARRYING OUT ACTIVITIES THAT SUPPLEMENT ACTIVITIES PERTAINING TO OPIOIDS UNDERTAKEN BY THE STATE AGENCY RESPONSIBLE FOR ADMINISTERING THE SUBSTANCE ABUSE PREVENTION AND TREATMENT BLOCK GRANT UNDER SUBPART II OF PART B OF TITLE XIX OF THE PUBLIC HEALTH SERVICE ACT (42 U.S.C. 300X21 ET SEQ.), AND TRIBES AND TRIBAL ORGANIZATIONS TO ADDRESS THE OPIOID CRISIS WITHIN THEIR COMMUNITIES.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Frankfort,
Kentucky
406012321
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 103% from $37,220,314 to $75,418,204.
Kentucky Cabinet For Health & Family Services was awarded
Kentucky Opioid Response : Expanding Access to Evidence-Based Interventions
Project Grant H79TI087770
worth $75,418,204
from the Division of Grants Management in September 2024 with work to be completed primarily in Frankfort Kentucky United States.
The grant
has a duration of 3 years and
was awarded through assistance program 93.788 Opioid STR.
The Project Grant was awarded through grant opportunity State Opioid Response Grants.
Status
(Ongoing)
Last Modified 9/26/25
Period of Performance
9/30/24
Start Date
9/29/27
End Date
Funding Split
$75.4M
Federal Obligation
$0.0
Non-Federal Obligation
$75.4M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for H79TI087770
Transaction History
Modifications to H79TI087770
Additional Detail
Award ID FAIN
H79TI087770
SAI Number
H79TI087770-3406108985
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75SAMH SAMHSA Division of Grants Management
Funding Office
75MT00 SAMHSA CENTER FOR SUBSTANCE ABUSE TREATMENT
Awardee UEI
LECJQDCLHVE5
Awardee CAGE
1M3S5
Performance District
KY-01
Senators
Mitch McConnell
Rand Paul
Rand Paul
Modified: 9/26/25